Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary Bartholin gland carcinoma].

Dagmara Klasa-Mazurkiewicz1, Janusz Emerich, Tomasz Milczek

  • 1II Kliniki Połoznictwa i Ginekologii Akademii Medycznej w Gdańsku.

Ginekologia Polska
|August 15, 2003
PubMed
Summary

Bartholin gland carcinoma is a rare cancer, accounting for less than 1% of female genital neoplasms. This case study discusses treatment challenges and reviews global literature on this rare malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reframing response in neoadjuvant chemotherapy for ovarian cancer: Integrating molecular and functional biomarkers.

Critical reviews in oncology/hematology·2026
Same author

Decoding the 2023 FIGO Staging System in Endometrial Cancer: A Practical, Visually Guided Framework for Molecular Risk-Adapted Care Incorporating the 2025 Risk Group Update.

Current oncology reports·2026
Same author

Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.

Antibodies (Basel, Switzerland)·2026
Same author

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.

Future oncology (London, England)·2026
Same author

Challenges in examining mentally Ill virgo intacta: a case of non-HPV cervical cancer and potential ovarian metastasis.

Ginekologia polska·2026
Same author

Case Report: Blood single-cell analysis of a IVB high-grade serous ovarian cancer patient presenting a favorable prognosis.

Frontiers in oncology·2025

Area of Science:

  • Gynecologic Oncology
  • Pathology

Background:

  • Bartholin gland carcinoma is an exceptionally rare malignancy, representing less than 1% of all neoplasms affecting the female genital tract.
  • Understanding the epidemiology and clinical presentation of this rare cancer is crucial for timely diagnosis and effective management.

Observation:

  • A case of a 52-year-old female diagnosed with Bartholin gland carcinoma is presented.
  • The clinical course and diagnostic process for this specific patient highlight the challenges associated with this rare tumor.

Findings:

  • The study reviews existing world literature on Bartholin gland carcinoma, synthesizing data on incidence, histology, and treatment outcomes.
  • Therapeutic strategies for Bartholin gland carcinoma often involve complex decision-making due to its rarity and potential for advanced presentation.

Implications:

  • This case and literature review underscore the need for increased awareness and specialized approaches in managing Bartholin gland carcinoma.
  • Further research into optimal treatment protocols for this rare gynecologic malignancy is warranted to improve patient outcomes.

Related Experiment Videos